Els Torreele

4.9k total citations · 1 hit paper
61 papers, 2.5k citations indexed

About

Els Torreele is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Els Torreele has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 14 papers in Economics and Econometrics and 11 papers in Infectious Diseases. Recurrent topics in Els Torreele's work include Research on Leishmaniasis Studies (11 papers), Trypanosoma species research and implications (10 papers) and Pharmaceutical Economics and Policy (10 papers). Els Torreele is often cited by papers focused on Research on Leishmaniasis Studies (11 papers), Trypanosoma species research and implications (10 papers) and Pharmaceutical Economics and Policy (10 papers). Els Torreele collaborates with scholars based in United Kingdom, Switzerland and Belgium. Els Torreele's co-authors include Piero Olliaro, Patrice Trouiller, Nathan Ford, James Orbinski, Richard Laing, Bernadette Bourdin Trunz, Reto Brun, Marcel Kaiser, Michael Bray and Michel Vaillant and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Els Torreele

59 papers receiving 2.4k citations

Hit Papers

Drug development for neglected diseases: a deficient mark... 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Els Torreele United Kingdom 20 1.2k 1.0k 482 399 339 61 2.5k
Filip Meheus Belgium 29 1.1k 0.9× 786 0.8× 150 0.3× 404 1.0× 330 1.0× 59 3.6k
Fábio Zicker Brazil 28 1.5k 1.2× 1.3k 1.3× 140 0.3× 277 0.7× 112 0.3× 86 2.6k
Bernard Pécoul Switzerland 18 854 0.7× 644 0.6× 219 0.5× 249 0.6× 315 0.9× 29 1.6k
Dominique Legros Switzerland 33 1.1k 0.9× 1.0k 1.0× 112 0.2× 596 1.5× 94 0.3× 92 3.2k
Nathalie Strub‐Wourgaft Switzerland 17 785 0.6× 515 0.5× 192 0.4× 249 0.6× 79 0.2× 40 1.3k
Monique Wasunna Kenya 20 1.6k 1.3× 1.0k 1.0× 208 0.4× 281 0.7× 131 0.4× 47 2.1k
Nancy Fullman United States 18 1.8k 1.4× 333 0.3× 51 0.1× 423 1.1× 358 1.1× 30 3.5k
Elaine W. Flagg United States 29 354 0.3× 816 0.8× 48 0.1× 306 0.8× 159 0.5× 63 3.6k
Emilie Alirol Switzerland 19 487 0.4× 393 0.4× 90 0.2× 239 0.6× 61 0.2× 30 2.0k
Kathryn Andrews United States 18 2.1k 1.7× 254 0.2× 57 0.1× 226 0.6× 194 0.6× 33 4.1k

Countries citing papers authored by Els Torreele

Since Specialization
Citations

This map shows the geographic impact of Els Torreele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Torreele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Torreele more than expected).

Fields of papers citing papers by Els Torreele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els Torreele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Torreele. The network helps show where Els Torreele may publish in the future.

Co-authorship network of co-authors of Els Torreele

This figure shows the co-authorship network connecting the top 25 collaborators of Els Torreele. A scholar is included among the top collaborators of Els Torreele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els Torreele. Els Torreele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torreele, Els, et al.. (2024). Health equity requires transformational change: Financial incentives based on worn-out market thinking will not deliver. SHILAP Revista de lepidopterología. 4(4). e0003147–e0003147.
2.
Ravinetto, Raffaella, Aquiles R. Henríquez-Trujillo, Prashanth Nuggehalli Srinivas, et al.. (2024). Shaping the future of global access to safe, effective, appropriate and quality health products. BMJ Global Health. 9(1). e014425–e014425. 5 indexed citations
3.
Goossens, Jolien, Mathieu Woillez, Serena Wright, et al.. (2024). Elucidating the migrations of European seabass from the southern north sea using mark-recapture data, acoustic telemetry and data storage tags. Scientific Reports. 14(1). 13180–13180. 3 indexed citations
4.
Olliaro, Piero & Els Torreele. (2024). The priority review voucher: a misconceived quid pro quo. BMJ Global Health. 9(12). e015933–e015933. 2 indexed citations
5.
Mazzucato, Mariana, et al.. (2024). An mRNA technology transfer programme and economic sustainability in health care. Bulletin of the World Health Organization. 102(5). 344–351. 5 indexed citations
6.
Torreele, Els, Michel D. Kazatchkine, Joanne Liu, et al.. (2023). Stopping epidemics when and where they occur. The Lancet. 401(10374). 324–328. 14 indexed citations
7.
Goossens, Jolien, Mathieu Woillez, Arnault Le Bris, et al.. (2023). Acoustic and archival technologies join forces: A combination tag. Methods in Ecology and Evolution. 14(3). 860–866. 9 indexed citations
8.
Goossens, Jolien, et al.. (2023). Fisheries measures protect European seabass groups with distinct habitat use differently. ICES Journal of Marine Science. 80(7). 1899–1910. 4 indexed citations
9.
Torreele, Els, et al.. (2023). Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?. The Lancet Infectious Diseases. 23(7). e253–e258. 14 indexed citations
10.
Torreele, Els, Daniel Wolfe, Michel D. Kazatchkine, et al.. (2023). From private incentives to public health need: rethinking research and development for pandemic preparedness. The Lancet Global Health. 11(10). e1658–e1666. 18 indexed citations
11.
Torreele, Els. (2020). Business-as-Usual will not Deliver the COVID-19 Vaccines We Need. Development. 63(2-4). 191–199. 8 indexed citations
12.
MacCarthy, Sarah, et al.. (2017). Engaging Human Rights in the Response to the Evolving Zika Virus Epidemic. SSRN Electronic Journal. 2 indexed citations
13.
Balasegaram, Manica, Peter Kolb, John C. McKew, et al.. (2017). An open source pharma roadmap. PLoS Medicine. 14(4). e1002276–e1002276. 15 indexed citations
14.
Bahia, Maria Terezinha, Isabel Mayer de Andrade, Lívia de Figueiredo Diniz, et al.. (2012). Fexinidazole: A Potential New Drug Candidate for Chagas Disease. PLoS neglected tropical diseases. 6(11). e1870–e1870. 143 indexed citations
15.
Tweats, David, Bernadette Bourdin Trunz, & Els Torreele. (2012). Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness). Mutagenesis. 27(5). 523–532. 29 indexed citations
16.
Torreele, Els, et al.. (2011). Self-sampling: a step in the right direction?. Flanders Marine Institute (Flanders Marine Institute). 1 indexed citations
17.
Priotto, Gérardo, Wilfried Mutombo, Sara Ghorashian, et al.. (2009). Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. The Lancet. 374(9683). 56–64. 365 indexed citations
18.
Torreele, Els, et al.. (2006). Global framework on essential health R&D. The Lancet. 367(9522). 1560–1561. 101 indexed citations
19.
Guthmann, Jean‐Paul, et al.. (2005). Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru. Tropical Medicine & International Health. 10(9). 856–862. 16 indexed citations
20.
Trouiller, Patrice, Piero Olliaro, Els Torreele, et al.. (2002). Drug development for neglected diseases: a deficient market and a public-health policy failure. The Lancet. 359(9324). 2188–2194. 546 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026